Bio-Techne (TECH) Revenue — Quarter Ended Mar 31, 2024
Reported revenue rose in the current quarter. The increase continued from the prior quarter and also exceeded the level of the same quarter one year earlier.
Key takeaway
Quarter ended Mar 31, 2024 · FY2024 Q3
Reported revenue rose in the current quarter. The increase continued from the prior quarter and also exceeded the level of the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$303.4M
Revenue reported for this quarter.
Quarter-over-quarter
+11.3%
Change from the immediately preceding quarter.
Year-over-year
+3.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$1.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2023 | $301.3M | +4.5% |
| Sep 30, 2023 | $276.9M | +2.7% |
| Dec 31, 2023 | $272.6M | +0.4% |
| Mar 31, 2024 | $303.4M | +3.2% |
Revenue performance
Revenue direction was positive for the quarter. Both sequential and year-ago comparisons show higher revenue.
Quarterly comparison
Revenue increased compared to the immediately preceding quarter. It also rose compared to the same quarter one year prior.
What to watch
Operating expenses rose while operating income declined versus the prior year quarter, a trend to monitor.